Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases

Life Sciences

Volumn 72, Issue 14, 2003, Pages 1549-1561

  Pelaia, G ^a,c   Vatrella, A ^b   Cuda, G ^a   Maselli, R ^a   Marsico, S A ^b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c Policlinico Mater Domini   (Italy)

Author keywords

Coactivators; Corepressors; Glucocorticoids; Mitogen activated protein kinases; Transcription factors

Indexed keywords

CORTICOSTEROID; CYTOPLASMIC RECEPTOR; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR;

ACETYLATION; ANTIINFLAMMATORY ACTIVITY; ASTHMA; CELL NUCLEUS; CHROMATIN STRUCTURE; CHRONIC INFLAMMATORY AIRWAY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DRUG ACTIVATION; DRUG ACTIVITY; DRUG SENSITIVITY; ENZYME ACTIVATION; GENE EXPRESSION; GENE REPRESSION; GENE SEQUENCE; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; HUMAN; MACROMOLECULE; MOLECULAR DYNAMICS; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; RECEPTOR BINDING; RESPIRATORY TRACT DISEASE; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 0037458439     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)02446-3     Document Type: Short Survey

References (86)

1. Adcock I.M. Steroid resistance in asthma: molecular mechanisms. American Journal of Respiratory and Critical Care Medicine. 154:1996;S58-S61.
2. Adcock I.M., Ito K. Molecular mechanisms of corticosteroid actions. Monaldi Archives for Chest Disease. 55:2000;256-266.
3. Akerblom I.E., Slater E.P., Beato M., Baxter J.D., Mellon P.L. Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer. Science. 241:1988;350-353.
4. Ayer D.E. Histone deacetylases: transcriptional repression with SINers and NuRDs. Trends in Cell Biology. 9:1999;193-198.
5. Ayroldi E., Migliorati G., Bruscoli S., Marchetti C., Zollo O., Cannarile L., D'Adamio F., Riccardi C. Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor-κB. Blood. 98:2001;743-753.
6. Bamberger C.M., Schulte H.M., Chrousos G.P. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocrine Reviews. 17:1996;245-261.
7. Barnes P.J. Beta-adrenergic receptors and their regulation. American Journal of Respiratory and Critical Care Medicine. 152:1995;838-860.
8. Barnes P.J., Greening A.P., Crompton G.K. Glucocorticoid resistance in asthma. American Journal of Respiratory and Critical Care Medicine. 152:1995;S125-S140.
9. Barnes P.J., Adcock I.M. NF-κB: a pivotal role in asthma and a new target for therapy. Trends in Pharmacological Sciences. 18:1997;46-50.
10. Barnes P.J., Adcock I.M. Transcription factors and asthma. European Respiratory Journal. 12:1998;221-234.
11. Barnes P.J., Pedersen S., Busse W.W. Efficacy and safety of inhaled corticosteroids: new developments. American Journal of Respiratory and Critical Care Medicine. 157:1998;S1-S53.
12. Barnes P.J. Therapeutic strategies for allergic diseases. Nature. 402(Supplement):1999;B31-B38.
13. Barnes P.J. Chronic obstructive pulmonary disease. New England Journal of Medicine. 343:2000;269-280.
14. Barnes P.J. Cytokine modulators as novel therapies for asthma. Annual Review of Pharmacology and Toxicology. 42:2002;81-98.
15. Beato M. Transcriptional control by nuclear receptors. FASEB Journal. 5:1991;2044-2051.
16. Beato M., Chavez S., Truss S. Transcriptional regulation by steroid hormones. Steroids. 61:1996;240-251.
17. Bertorelli G., Bocchino V., Olivieri D. Heat shock protein interactions with the glucocorticoid receptor. Pulmonary Pharmacology and Therapeutics. 11:1998;7-12.
18. Bickel M., Cohen R.B., Pluznik D.H. Post-transcriptional regulation of granulocyte-macrophage colony-stimulating factor synthesis in murine T cells. Journal of Immunology. 145:1990;840-845.
19. Borish L., Mascali J.J., Dishuck J., Beam W.R., Martin R.J., Rosenwasser L.J. Detection of alveolar macrophage-derived IL-1β in asthma: inhibition with corticosteroids. Journal of Immunology. 149:1992;3078-3082.
20. Caelles C., Gonzalez-Sancho J.M., Munoz A. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes & Development. 11:1997;3351-3364.
21. Cembrzynska-Nowak M., Szklarz E., Inglot A.D., Teodorczyk-Injeyan J.A. Elevated release of tumor necrosis factor-alpha and interferon-gamma by bronchoalveolar leukocytes from patients with bronchial asthma. American Review of Respiratory Disease. 147:1993;291-295.
22. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature. 410:2001;37-40.
23. De Bosscher K., Vanden Berghe W., Vermeulen L., Plaisance S., Boone E., Haegeman G. Glucocorticoids repress NF-κB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proceedings of the National Academy of Sciences USA. 97:2000;3919-3924.
24. Dong C., Davis R.J., Flavell R. MAP kinases in the immune response. Annual Review of Immunology. 20:2002;55-72.
25. Fernandes D., Guida E., Koutsoubos V., Harris T., Vadiveloo P., Wilson J.W., Stewart A.G. Glucocorticoids inhibit proliferation, cyclin D1 expression, and retinoblastoma protein phosphorylation, but not activity of the extracellular-regulated kinases in human cultured airway smooth muscle. American Journal of Respiratory Cell and Molecular Biology. 21:1999;77-88.
26. Flower R.J., Rothwell N.J. Lipocortin-1: cellular mechanisms and clinical relevance. Trends in Pharmacological Sciences. 15:1994;71-76.
27. Franchimont D., Galon J., Gadina M., Visconti R., Zhou Y., Aringer M., Frucht D.M., Chrousos G.P., O'Shea J.J. Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes. Journal of Immunology. 164:2000;1768-1774.
28. Glass C.K., Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes and Development. 14:2000;121-141.
29. Gonzalez M.V., Gonzalez-Sancho J.M., Caelles C., Munoz A., Jimenez B. Hormone-activated nuclear receptors inhibit the stimulation of the JNK and ERK signalling pathways in endothelial cells. FEBS Letters. 459:1999;272-276.
30. Gronemeyer H. Control of transcription activation by steroid hormone receptors. FASEB Journal. 6:1992;2524-2529.
31. Hastie A.T., Kraft W.K., Nyce K.B., Zangrilli J.G., Musani A.I., Fish J.E., Peters S.P. Asthmatic epithelial cell proliferation and stimulation of collagen production. American Journal of Respiratory and Critical Care Medicine. 165:2002;266-272.
32. Holgate S.T., Lackie P., Wilson S., Roche W., Davies D. Bronchial epithelium as a key regulator of airway allergen sensitization and remodeling in asthma. American Journal of Respiratory and Critical Care Medicine. 162:2000;S113-S117.
33. Holgate S.T., Lackie P.M., Howarth P.H., Roche W.R., Puddicombe S.M., Richter A., Wilson S.J., Holloway J.W., Davies D.E. Invited lecture: activation of the epithelial mesenchymal trophic unit in the pathogenesis of asthma. International Archives of Allergy and Immunology. 124:2001;253-258.
34. Ip Y.T., Davis R.J. Signal transduction by the c-Jun N-terminal kinase (JNK): from inflammation to development. Current Opinion in Cell Biology. 10:1998;205-219.
35. Irusen E., Matthews J.G., Takahashi A., Barnes P.J., Chung K.F., Adcock I.M. p38 mitogen-activated protein kinase-induced glucocorticoid phosphorylation reduces its activity: role in steroid-insensitive asthma. Journal of Allergy and Clinical Immunology. 109:2002;649-657.
36. Ito K., Barnes P.J., Adcock I.M. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1β-induced histone H4 acetylation on lysines 8 and 12. Molecular Cell Biology. 20:2000;6891-6903.
37. Ito K., Lim S., Caramori G., Chung K.F., Barnes P.J., Adcock I.M. Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB Journal. 15:2001;1110-1112.
38. Jeffery P.K. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax. 53:1998;129-136.
39. Kassel O., Sancono A., Kratzschmar J., Kreft B., Stassen M., Cato A.C. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO Journal. 20:2001;7108-7116.
40. Kern J.A., Lamb R.J., Reed J.C., Daniele R.P., Nowell P.C. Dexamethasone inhibition of interleukin-1β production by human monocytes. Posttranscriptional mechanisms. Journal of Clinical Investigation. 81:1988;237-244.
41. Lane S.J., Adcock I.M., Richards D., Hawrylowicz C., Barnes P.J., Lee T.H. Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes. Journal of Clinical Investigation. 102:1998;2156-2164.
42. Lasa M., Brook M., Saklatvala J., Clark A.R. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Molecular Cell Biology. 31:2001;771-780.
43. Luisi B.F., Xu W.X., Otwinowski Z., Freedman L.P., Yamamoto K.R. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature. 352:1991;497-505.
44. Maddox L., Schwartz D.A. The pathophysiology of asthma. Annual Review of Medicine. 53:2002;477-498.
45. McKay L.I., Cidlowski J.A. Molecular control of immune/inflammatory responses: interactions between nuclear factor-κB and steroid receptor-signaling pathways. Endocrine Reviews. 20:1999;435-459.
46. McKay L.I., Cidlowski J.A. CBP (CREB binding protein) integrates NF-κB (nuclear factor-κB) and glucocorticoid receptor physical interactions and antagonism. Molecular Endocrinology. 14:2000;1222-1234.
47. Mitchell P.J., Tjian R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science. 245:1989;371-378.
48. Mozo L., Gayo A., Suarez A., Rivas D., Zamorano J., Gutierrez C. Glucocorticoids inhibit IL-4 and mitogen-induced IL-4Rα chain expression by different post-transcriptional mechanisms. Journal of Allergy and Clinical Immunology. 102:1998;968-976.
49. Guidelines for the diagnosis and management of asthma: expert panel report 2. 1997;U.S. Department of Health and Human Services, National Heart, Lung, and Blood Institute, publication no. 97-4051, Bethesda.
50. Newton R., Seybold J., Kuttert L.M., Bergmann M., Barnes P.J. Repression of cyclooxygenase-2 and prostaglandin E2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA. Journal of Biological Chemistry. 273:1998;32312-32321.
51. Global strategy for the diagnosis, management, and prevention of COPD. 2001;U.S. Department of Health and Human Services, National Heart, Lung, and Blood Institute, NIH publication no. 2701, Bethesda.
52. Nightingale K.P., Wellinger R.E., Sogo J.M., Becker P.B. Histone acetylation facilitates RNA polymerase II transcription of the Drosophila hsp26 gene in chromatin. EMBO Journal. 17:1998;2865-2876.
53. Nightingale J.A., Rogers D.F., Fan Chung K., Barnes P.J. No effect of inhaled budesonide on the response to inhaled ozone in normal subjects. American Journal of Respiratory and Critical Care Medicine. 161:2000;479-486.
54. Nissen R.M., Yamamoto K.R. The glucocorticoid receptor inhibits NF-κB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes & Development. 14:2000;2314-2329.
55. Olivieri D., Chetta A., Del Donno M., Bertorelli G., Canalini A., Pesci A., Testi R., Foresi A. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. American Journal of Respiratory and Critical Care Medicine. 155:1997;1864-1871.
56. 2-adrenergic receptors and the implications for bronchial asthma: an update. Monaldi Archives for Chest Disease. 49:1994;125-130.
57. Pelaia G., Vatrella A., Calabrese C., Mazzarella G., Marsico S.A. New perspectives in asthma treatment. Allergy. 55(Supplement 61):2000;60-66.
58. Pelaia G., Cuda G., Vatrella A., Grembiale R.D., De Sarro G.B., Maselli R., Costanzo F.S., Avvedimento V.E., Rotiroti D., Marsico S.A. Effects of glucocorticoids on activation of c-Jun N-terminal, extracellular signal-regulated, and p38 MAP kinases in human pulmonary endothelial cells. Biochemical Pharmacology. 62:2001;1719-1724.
59. Peppel K., Vinci J.M., Baglioni C. The AU-rich sequences in the 3′ untranslated region mediate the increased turnover of interferon mRNA induced by glucocorticoids. Journal of Experimental Medicine. 173:1991;349-355.
60. Pernis A.B., Rothman P.B. JAK-STAT signaling in asthma. Journal of Clinical Investigation. 109:2002;1279-1283.
61. Pfahl M. Nuclear receptor/AP-1 interaction. Endocrine Reviews. 14:1993;651-658.
62. Rahman I., MacNee W. Role of transcription factors in inflammatory lung diseases. Thorax. 53:1998;601-612.
63. Rahman I., MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. European Respiratory Journal. 16:2000;534-554.
64. Rahman I. Oxidative stress, transcription factors and chromatin remodeling in lung inflammation. Biochemical Pharmacology. 64:2002;935-942.
65. Ray A., LaForge K.S., Sehgal P.B. On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion. Molecular and Cell Biology. 10:1990;5736-5746.
66. Ray A., Prefontaine K.E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proceedings of the National Academy of Sciences USA. 91:1994;752-756.
67. Redington A.E., Madden J., Frew A.J., Djukanovic R., Roche W.R., Holgate S.T., Howarth P.H. Transforming growth factor-β1 in asthma: measurement in bronchoalveolar lavage. American Journal of Respiratory and Critical Care Medicine. 156:1997;642-647.
68. Riccardi C., Cifone M.G., Migliorati G. Glucocorticoid hormone-induced modulation of gene expression and regulation of T-cell death: role of GITR and GILZ, two dexamethasone-induced genes. Cell Death and Differentiation. 6:1999;1182-1189.
69. Rider L.G., Hirasawa N., Santini F., Beaven M.A. Activation of the mitogen-activated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells. Journal of Immunology. 157:1996;2374-2380.
70. Rogatsky I., Logan S.K., Garabedian M.J. Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. Proceedings of the National Academy of Sciences USA. 95:1998;2050-2055.
71. Saetta M., Turato G., Maestrelli P., Mapp C.E., Fabbri L.M. Cellular and structural bases of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 163:2001;1304-1309.
72. Smith D.F., Toft D.O. Steroid receptors and their associated proteins. Molecular Endocrinology. 7:1993;4-11.
73. Song C.-Z., Tian X., Gelehrter T.D. Glucocorticoid receptor inhibits transforming growth factor-β signaling by directly targeting the transcriptional activation function of Smad3. Proceedings of the National Academy of Sciences USA. 96:1999;11776-11781.
74. Sousa A.R., Lane S.J., Soh C., Lee T.H. In vivo resistance to corticosteroids in bronchial asthma is associated with enhanced phosphorylation of Jun N-terminal kinase and failure of prednisolone to inhibit Jun N-terminal kinase phosphorylation. Journal of Allergy and Clinical Immunology. 104:1999;565-574.
75. Stoecklin E., Wissler M., Gouilleux F., Groner B. Functional interactions between Stat5 and the glucocorticoid receptor. Nature. 383:1996;726-728.
76. Swantek J.L., Cobb M.H., Geppert T.D. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-α) translation: glucocorticoids inhibit TNF-α translation by blocking JNK/SAPK. Molecular Cell Biology. 17:1997;6274-6282.
77. Trautmann A., Schmid-Grendelmeier P., Kruger K., Crameri R., Akdis M., Akkaya A., Brocker E.-B., Blaser K., Akdis C.A. T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma. Journal of Allergy and Clinical Immunology. 109:2002;329-337.
78. Trigg C.J., Manolitsas N.D., Wang J., Calderon M.A., McAulay A., Jordan S.E., Herdman M.J., Jhalli N., Duddle J.M., Hamilton S.A., Devalia J.L., Davies R.J. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. American Journal of Respiratory and Critical Care Medicine. 150:1994;17-22.
79. Tsai M.-J., O'Malley B.W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annual Review of Biochemistry. 63:1994;451-486.
80. Ulloa L., Doody J., Massaguè J. Inhibition of transforming growth factor-β/SMAD signalling by the interferon-gamma/STAT pathway. Nature. 397:1999;710-713.
81. Umland S.P., Schleimer R.P., Johnston S.L. Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma. Pulmonary Pharmacology and Therapeutics. 15:2002;35-50.
82. Ventura J.-J., Roncero C., Fabregat I., Benito M. Glucocorticoid receptor down-regulates c-Jun amino terminal kinases induced by tumor necrosis factor α in fetal rat hepatocyte primary cultures. Hepatology. 29:1999;849-857.
83. Webster J.C., Cidlowski J.A. Mechanisms of glucocorticoid-receptor-mediated repression of gene expression. Trends in Endocrinology and Metabolism. 10:1999;396-402.
84. Widmann C., Gibson S., Jarpe M.B., Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiological Reviews. 79:1999;143-180.
85. Winzen R., Kracht M., Ritter B., Wilhelm A., Chen C.-Y.A., Shyu A.-B., Muller M., Gaestel M., Resch K., Holtmann H. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO Journal. 18:1999;4969-4980.
86. Pelaia G, Cuda G, Vatrella A, Fratto D, Grembiale RD, Tagliaferri P, Maselli R, Costanzo FS, Marsico SA. Effects of TGF-β and budesonide on MAPK activation and apoptosis in airway epithelial cells. American Journal of Respiratory Cell and Molecular Biology (submitted for publication).